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Novel human mutation and 
CRISPR/Cas genome-edited mice 
reveal the importance of C-terminal 
domain of MSX1 in tooth and 
palate development
Silvia Naomi Mitsui1,2, Akihiro Yasue1, Kiyoshi Masuda3, Takuya Naruto3, 
Yoshiyuki Minegishi4, Seiichi Oyadomari2, Sumihare Noji5, Issei Imoto3 & Eiji Tanaka1
Several mutations, located mainly in the MSX1 homeodomain, have been identified in non-syndromic 
tooth agenesis predominantly affecting premolars and third molars. We identified a novel frameshift 
mutation of the highly conserved C-terminal domain of MSX1, known as Msx homology domain 6 
(MH6), in a Japanese family with non-syndromic tooth agenesis. To investigate the importance of MH6 
in tooth development, Msx1 was targeted in mice with CRISPR/Cas system. Although heterozygous 
MH6 disruption did not alter craniofacial development, homozygous mice exhibited agenesis of lower 
incisors with or without cleft palate at E16.5. In addition, agenesis of the upper third molars and the 
lower second and third molars were observed in 4-week-old mutant mice. Although the upper second 
molars were present, they were abnormally small. These results suggest that the C-terminal domain of 
MSX1 is important for tooth and palate development, and demonstrate that that CRISPR/Cas system 
can be used as a tool to assess causality of human disorders in vivo and to study the importance of 
conserved domains in genes.
Non-syndromic tooth agenesis has been associated with mutations in a variety of genes involved in tooth mor-
phogenesis. Among them, mutations in MSX1 and PAX9 have been reported in premolar and molar agenesis, 
respectively1–3. Additionally, AXIN2, WNT10A, and EDA mutations produce severe tooth agenesis of variable 
patterns4–6.
The MSX homeobox gene family encodes transcription factors that play important roles in inductive tis-
sue interaction during vertebrate development7,8. Msx1 is expressed in developing limb buds and craniofacial 
structures, including the neural crest, branchial arches, and sensory placodes9,10. It is markedly expressed in the 
dental papilla and follicle during the cap stage, declining progressively in the bell stage11. The MSX1 protein has 
seven ancient and highly conserved Msx homology (MH) domains that act as binding or functional domains12. 
In humans, MSX1 mutations have also been associated with syndromic tooth agenesis in Wolf-Hirschhorn 
syndrome, Witkop syndrome, and orofacial clefting13–15. Furthermore, MSX1 mutations are present in 2% of 
non-syndromic cleft lip and palate cases16,17.
The availability of limited number of cases or families, reduced penetrance and locus heterogeneity are 
some of the factors limiting traditional strategies to identify disease mutations18. Although, with the advert 
of next-generation sequencing platforms, part of the limitations have been possible to overcome with proper 
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strategies, biological validation is indispensable to assess the causality of uncharacterized variants and genes, 
especially when is identified in a single family19.
Animal models have contributed greatly to elucidate the molecular and developmental mechanisms of 
human diseases as well as potential therapeutic targets. Meanwhile, transcription activator-like effector nucleases 
(TALENs) and the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 
(Cas) system enable efficient and precise genome editing20,21. These techniques have been used to produce gene 
mutations in diverse organisms and thereby to assess the causality of human mutations in animal models22–24.
Here, we report a novel tooth agenesis-causing mutation in the C-terminus of MSX1. Genotype-phenotype 
relation was analysed through CRISPR/Cas-mediated genome editing in mice.
Results
Clinical data. A family pedigree indicated autosomal-dominant inheritance of oligodontia (Fig. 1a). The 
proband (II:2), a 14-year-old girl, had agenesis of all maxillary first and second bicuspids, the mandibular left 
central incisor, and second bicuspid (Fig. 1b,c). Her father (II:1) had agenesis of all maxillary first and second 
bicuspids, the maxillary left third molar, the mandibular lateral incisors and second bicuspids, and both man-
dibular third molars (Fig. 1b,c); his mandibular left first and second molars had been extracted. Tooth agenesis 
of the proband’s brother was confirmed by interview only. No other physical anomalies, such as oral clefting or 
abnormalities of the nails, skin, hair, or sweat glands, were observed in I:1, II:1, or II:2.
Mutation analyses. The proband was screened for mutations of genes previously related to tooth agenesis 
(i.e., PAX9, AXIN2, EDA, WNT10A, etc.) by targeted exome sequencing (TES), with next generation technol-
ogy. A heterozygous nucleotide substitution in exon 4 of WNT10A (c.874 A> G, p.S292G) was detected, but not 
observed in family members by Sanger sequencing. This substitution had a 0.4% frequency in 1,208 sampled 
Japanese individuals [Human Genetic Variation Database (HGVD), http://www.genome.med.kyoto-u.ac.jp/
SnpDB/], suggesting that it was an unrelated de novo mutation.
No other single nucleotide variations, small insertions and/or deletions (indels), or gross gains or losses 
were observed around other candidate genes. However, a segment of exon 2 in MSX1 was covered by only a 
few TES reads. Sanger sequencing of this region revealed a heterozygous guanine deletion in exon 2 of MSX1 
(NM_002448.3: c.844delG) in the proband (II:2) and her affected father and brother (I:1, II:1), but not in her 
unaffected mother (Fig. 1d, data not shown). This deletion was predicted to cause a frameshift (p.A282Rfs*21) 
that alters 21 C-terminal amino acids starting from residue 282, creating a premature stop codon that results in 
a 301-, rather than 303-, residue truncated protein lacking MH6 domain (Fig. 1e). The sequence around MH6 is 
highly conserved in mammals (Fig. 1e).
MutationTaster (http://www.mutationtaster.org/) predicted that the detected deletion mutation would be 
disease-causing (probability = 0.999). It is not present in human genome variation databases [i.e., 1000 Genomes 
Project database (http://www.1000genomes.org/), NHLBI GO Exome Sequencing Project (ESP6500, http://evs.
gs.washington.edu/EVS/), HGVD and integrative Japanese Genome Variation Database (iJGVD, https://ijgvd.
megabank.tohoku.ac.jp/)] nor in disease-causing mutation databases [i.e., Human Gene Mutation Database 
Professional 2016.1 (HGMD, http://www.hgmd.org/) and ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/)]. 
Hence, this MSX1 mutation seems to be a novel oligodontia-causing genetic alteration inherited in an autosomal 
dominant manner.
Generation of MH6-disrupted mice. Most MSX1 variants isolated from patients with tooth agenesis 
to date involved single amino acid substitutions in the highly conserved homeodomain/MH4 sequence; few 
frameshift, nonsense, and splice-site mutations that lead to premature termination have been examined. To verify 
genotype-phenotype correlation in vivo, MH6 was targeted using CRISPR/Cas system in mice. A gRNA targeting 
upstream region of MH6 was designed and synthesized in vitro (Fig. 2a), and then co-injected with Cas9 mRNA 
into one-cell zygotes. Among the mosaic mice produced (17 of 20 F0), three mutant alleles were selected for 
phenotype analysis: in-frame 21-nucleotide deletion (Msx1−21) and frameshift 28-nucleotide deletion (Msx1−28) 
causing premature stop codon upstream of MH6; and single-nucleotide insertion (Msx1+1) causing a frameshift 
mutation affecting MH6 (Fig. 2b,c). The selected mice were mated to wild-type BDF1 mice.
Secondary cleft palate and tooth agenesis in MH6 deficient mice. Because conventional 
Msx1-deficient mice is neonatally lethal25, phenotypes were first analyzed at E16.5. Coronal sections of MsxWT/−21 
and Msx1−21/−21 embryos showed normal tooth and palate development (Fig. 3a–f, data not shown). Although 
MsxWT/−28 mice showed normal palate and tooth development, two phenotypes were observed in Msx1−28/−28 
mice: secondary cleft palate with agenesis of lower incisors; and agenesis of the lower incisors with a thin pal-
ate (Fig. 3g–o). Because one-third of the Msx1−28/−28 pups (5/15) exhibited palate development, phenotypes of 
4-week-old mice were analyzed. All newborn homozygotes with cleft palates died neonatally, whereas those 
with a thin palate were viable. Micro-CT at 4 weeks old revealed no dentition anomalies in mice with in-frame 
homozygous mutations (Fig. 4e–h), but in homozygous Msx1−28/−28 mice, it revealed agenesis of the upper third 
molar and lower second and third molars as well as undersized upper second molars, in addition to the missing 
lower incisors observed at E16.5 (Fig. 4m–p). Similar phenotypes were observed in mice with compound hete-
rozygous mutations affecting MH6 (Figs 3p–u and 4q–t).
Discussion
In this study, we have reported a novel frameshift mutation in exon 2 of MSX1 in a family with autosomal-dominant 
inheritance of non-syndromic oligodontia. The proband and her father had tooth agenesis phenotypes that 
were similar to those observed with previously identified MSX1 mutations26,27. The guanine deletion identified 
(p.A282Rfs*21) is upstream of the MH6 domain and produced a frameshift that replaces the highly conserved 
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MH6 sequence with an unrelated peptide. A heterozygous mutation disrupting the original stop codon and open-
ing the reading frame was reported previously in a familial case of non-syndromic tooth agenesis28, but the pres-
ently identified mutation is the first to affect the entire MH6 domain.
Heterozygous MH6 disruption in model mice did not alter craniofacial development, whereas homozygous 
disruption resulted in agenesis of lower incisors with or without cleft palate at E16.5 as well as agenesis of the 
upper third molars and the lower second and third molars in 4-week-old mice. It is noteworthy that although the 
MSX1 mutation in the proband family showed autosomal dominant inheritance, tooth agenesis and cleft palate 
were observed only in the bialellic disruption of MH6. Our findings are in line with previous studies report-
ing several nonsense oligodontia-causing mutations located in MH4 or its upstream regions with autosomal 
Figure 1. Identification of a heterozygous mutation in MSX1 in a Japanese family with non-syndromic 
oligodontia. (a) Pedigree of affected (black filled symbols) father, son, and daughter (proband, P), and 
unaffected mother (open symbol). (b) Panoramic radiographs of the proband and her father. (c) Summary of 
permanent tooth agenesis in the proband and father (*affected tooth). (d) Chromatograms of MSX1 segment 
in affected (I:1 and II:2) and unaffected (I:2) individuals. The arrow indicates frameshift mutation. DNA and 
corresponding amino-acid sequences of wild-type (WT) and mutant (Mut) alleles are shown below. (e) MSX1 
domains (upper) and amino acid sequence conservation around MH6 in seven species (lower). Rectangles and 
the arrow represent MH domains and the location of the identified mutation (c.844delG, p.Ala282Argfs*21), 
respectively. Altered amino acid sequence in the proband is highlighted in red.
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dominant trait29,30, although failure in tooth and palate development was inherited in a autosomal recessive man-
ner in conventional Msx1-deficient mice with disrupted MH4 domain25.
The MH6 is the most C-terminal domain of MSX1, known as a PIAS binding domain31. It is necessary for 
localization of the MSX1 protein in the nuclear periphery, which enables repression of MyoD in myoblasts31. In 
addition, it has been reported that Msx1 and Msx2 act as potent transcriptional activators of the promoter of the 
Heat shock 70 kDa protein 1B gene HSPA1B through their C-terminal domains32. Although the MH6 domain 
has not been reported to interact with genes involved in craniofacial development, our results suggest that it is 
important in MSX1 function during tooth and palate development.
Most of the MSX1 mutations that have been identified previously as causing non-syndromic tooth agenesis 
are located in MH4 domain, or in upstream regions that affect MH41,27,33. The MH4 domain is involved in DNA 
binding and protein-protein interactions34,35. Functions of MH4-containing proteins are not mediated solely 
through protein-DNA interactions. It has been demonstrated that transcriptional repression by MSX1 occurs 
in the absence of DNA-binding sites; the repressor function is attributed to multiple domains in the N- and 
C-terminal regions of MSX136. In silico analysis studies have indicated that missense mutations affecting MH4 in 
MSX1 alter the encoded 3D structures of the proteins, specifically by destabilizing the helix-turn-helix motif or 
Figure 2. Msx1 targeting using CRISPR/Cas system. (a) Targeted region in mouse Msx1. PAM sequence is 
highlighted in red. HD, homeodomain. (b) Sequences of the three mutant alleles observed in F0 animals and 
selected for further analyses. PAM sequence is highlighted in red in the wild-type (WT) sequence; the target 
sequence is underlined. The arrow indicates the guanine affected in the proband. Stop codon is highlighted 
in yellow (c) Amino-acid sequences and schematic representation of the wild-type (WT) and mutant MSX1 
proteins. Striped areas indicate variant amino acids. Arrow indicates the conserved amino-acid affected in 
proband.
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altering its protein-DNA interactions37,38. Moreover in vitro studies have demonstrated that nuclear localization 
of MSX1 protein is mediated by the homeodomain37.
Finnerty et al. proposed that the non-random distribution of mutations in MH domains may be related to 
the yet unexplained genotype-phenotype correlation12. Specifically, they suggested that mutations that disrupt 
the MH1C or MH6 domain is associated with cleft disorders and may act through a dominant negative mecha-
nism. On the other hand, tooth agenesis phenotypes attributed to MH1N and MH4 domain mutations have been 
explained by functional redundancy from the MSX2 domains, which are also highly conserved. Our findings 
contradict these observations, because the MH6 domain-affected members showed non-syndromic tooth agen-
esis phenotype.
Previously reported Msx1-deficient mice generated by MH4-disruptive insertion of the neomycin resistance 
gene exhibited cleft palate, alveolar bone deficiency in maxilla and mandible, bud stage arrest of tooth develop-
ment, and other craniofacial abnormalities25. Unlike conventional Msx1 deficient mice, our Msx1−28/−28 mice 
lacked only lower incisors, which were also absent in Pax9;+/-Msx1+/− mice39. In addition, our observation of two 
different phenotypes in the palate of MH6-disrupted mice is consistent with previous findings. Jia et al. found that 
~16% of Bmp;f/fWnt1Cre mutant mice had cleft palate40 and Nakatomi et al. found that 39% of Pax9;−/− Msx1−/− 
mice were born with unilateral or bilateral cleft lip39.
This study has some limitations. First, we did not analyze possible off-target effects of the CRISPR/Cas9 mod-
ification. However, it is important to note that the genotype-phenotype correlations were maintained across 
mouse generations. Moreover, the phenotypes in MH6-disrupted mice were consistently observed in Msx1−28/−28 
and Msx−1/+28. Second, although mouse models have been extensively used to understand tooth morphogenesis 
and to establish disease models, there are differences from humans in terms of number of the teeth. Mice have 
monophyodont dentition, presenting a single continuously growing incisor separated from three molars in each 
quadrant. In contrast, humans have dyphyodont dentitions with all four types of teeth. Therefore, further studies 
in non-human primates, such as marmosets in which premolars are observed, should be conducted.
Figure 3. Coronal sections of Msx1 mutant mice at E16.5. Samples are stained with hematoxylin and eosin. 
Asterisks indicate agenesis of lower incisors. Scale bars: 300 μ m in the palate, 100 μ m in the tooth bud.
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In conclusion, we identified a novel mutation in a familial case of non-syndromic tooth agenesis affect-
ing the MH6 domain of MSX1. Genotype-phenotype correlation was corroborated through CRISPR/Cas 
system-mediated gene targeting in mice. Thus, the present findings demonstrate that MH6 is functionally 
required in MSX1 for tooth and palate development.
Methods
Subjects. A Japanese family with tooth agenesis was enrolled. The pedigree was made based on clinical exam-
ination of the proband and interviews with all available family members. The diagnosis of oligodontia in the 
proband was verified by panoramic radiographs. Written informed consent was obtained from all participants. 
This study complied with the tenets of the Declaration of Helsinki and was approved by the ethics committee of 
Tokushima University Hospital (H24-8, H26-40).
TES and Sanger sequencing. Genomic DNA was extracted from saliva samples with the Oragene® DNA 
collection kit (OG-500, DNA Gentotec Inc., Ottawa, Canada), according to the manufacturer’s instructions. TES 
was performed with TruSight One sequencing panel (Illunima, San Diego, CA) and MiSeq benchtop sequencer 
(Illumina). Alignment of sequencing reads to a human reference genome (hg19), duplicate read removal, local 
realignment around indels, base quality score recalibration, variant calling, and detailed annotation were per-
formed as described elsewhere41,42. Copy-number variations were detected relative to NGS data as described 
elsewhere41,42. Direct Sanger sequencing using polymerase-chain reaction products and BigDye Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) were conducted with ABI 3500xL Genetic 
Analyzer (Applied Biosystems). Sequencing results were compared by BLAST (http://blast.ddbj.nig.ac.jp/top-j.
html). Putative functional consequences of mutations were predicted in silico with MutationTaster.
Animals. All animal experiments were approved by the Ethical Committee of Tokushima University for 
Animal Research (Approval number: 12064, T27–16). All procedures were conducted in accordance with the 
Guidelines for Animal Experiments of Tokushima University.
Production of sgRNA and Cas9 mRNA. Two oligonucleotides (Forward, TAGGCGCGCTGGAAAG 
GGCCAG; Reverse, AAACCTGGCCCTTTCCAGCGCG) including the target sequence in Msx1 were annealed 
and cloned into the BsaI site of the pDR274 plasmid (Addgene, Cambridge, MA). The Cas9 plasmid (pMLM3613, 
Addgene) and target sequence-inserted pDR274 were digested with PmeI and DraI, respectively. Linearized tem-
plates were transcribed with mMessage mMachine T7 ULTRA kits (Ambion, Austin, TX), and then treated with 
DNase I, according to the manufacturer’s instructions. Cas9-encoding mRNA and sgRNA were suspended in 
appropriate volumes of RNase-free water, after purification by phenol-chloroform-isoamylalcohol extraction and 
isopropanol precipitation.
Figure 4. Micro-CT images of 4-week-old Msx1 mutant mice. Arrowheads indicate tooth agenesis. M1, first 
molar; M2, second molar; and M3, third molar.
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RNA microinjection into embryos. Cas9-encoding mRNA (10 ng/μ l) and sgRNA (1 ng/μ l) quantified by 
a NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, DE) were co-injected 
into the cytoplasm of fertilized eggs, obtained after mating BDF1 (C57BL/6 × DBA2 F1) male with superovulated 
female mice. Injected eggs were cultured overnight in M16 medium (Sigma, St. Louis, MO) at 37 °C in 5% CO2. 
Two-cell embryos were then transferred into the oviducts of pseudopregnant MCH(ICR) mice.
Mouse genotyping. To verify CRISPR/Cas9-mediated mutations, genomic DNA was extracted from tail 
biopsies. The genomic regions flanking the gRNA target were PCR amplified with KOD-Plus-Neo (Toyobo, 
Osaka, Japan) and an Msx1-specific primer pair (Forward, 5′ -CGCAAGCACAAGACTCTCTTT-3′ ; and Reverse 
5′ -AGGGGTCAGATGAGGAAGGT-3′ ), according to the manufacturer′ s instructions. PCR products were puri-
fied for direct or cloned sequencing using Wizard SV Gel and PCR Clean-up System (Promega). For mosaic 
F0 genotyping, purified PCR amplicons were cloned into plasmids using DynaExpress TA PCR Cloning Kits 
(BioDynamics Laboratory, Tokyo, Japan). Isolated plasmids from each sample were sequenced with a BigDye 
Terminator Sequence Kit ver. 3.1 and an ABI 3500xL Genetic Analyzer (Applied Bioystems). After targeting 
verification, F0 mice were mated with wild-type BDF1 mice to propagate alleles of interest. F2 to F4 generations 
were analyzed.
Histology and Micro-computed tomopraphy (Micro-CT). Dissected samples at E16.5 were 
immerse-fixed immediately in 4% paraformaldehyde, dehydrated in ethanol, and paraffin-processed for section-
ing. Serial coronal sections (7 μ m) were stained with hematoxylin and eosin.
Maxillae and mandibles of 4-week-old mice were resected and fixed overnight in 70% ethanol after removal of 
soft tissues. Molars and incisors were analyzed by high-resolution micro-CT (Skyscan 1176, operated at 50 kV and 
200 μ A; Bruker-microCT, Kontich, Belgium). Two-dimensional images were used to generate three-dimensional 
(3D) renderings with CTVox 3D Creator software (version 3.0, Bruker). The resolution of the micro-CT images 
was 9 μ m per pixel.
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